Kuke Music Holding Limited American Depositary Shares, each representing one Ordinary Share

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms. Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Soligenix, Inc. (NASDAQ: SNGX) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA. Longeveron Inc. (NASDAQ: LGVN) surged 54% to $2.6350 following insider buys from multiple company executives. SuperCom Ltd. (NASDAQ: SPCB) shares gained 39.4% to $0.3849 after jumping around 18% on Friday. Piedmont Lithium Inc. (NYSE: PLL) shares gained 32.1% to $16.75 following a 5% decline on Friday. Snap One Holdings Corp. (NASDAQ: SNPO) surged 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies. Organovo Holdings, Inc. (NASDAQ: ONVO) shares surged 30.9% to $1.32 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo. Kuke Music Holding Limited (NASDAQ: KUKE) jumped 27% to $2.7650. HUB Cyber Security Ltd. (NASDAQ: HUBC) gained 24% to $1.61 after gaining over 11% on Friday. Edgio, Inc. (NASDAQ: EGIO) gained 24% to $22.18. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ...

Related tickers: YSG, DXYZ, ONVO, KUKE, QTTB, IMCC, LGVN, NVX, SPCB, CMAX, CENX, RARE, SNPO, EXTR, MRNS, LOCL, INFA, AEYE, NXPL, RENT, TCON, HUBC, WIRE, SES, BTCY, SWVL, CYN, PMN, EGIO, DM, BHVN, PSNY, MPW, VERU, PROK, PLL, ADIL, SRFM, OCX, ATHE, NMRA, BB, KAVL, COCH, SPWR, VIAO, MNDR, SNGX.

Shares of Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter earnings. Cardlytics posted adjusted earnings of 14 cents per share, beating market estimates of 12 cents per share, according to data from Benzinga Pro. The company said it sees first-quarter revenue of $70 million to $73 million, versus expectations of $66.46 million. Cardlytics shares jumped 36.6% to $11.18 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Fisker Inc. (NYSE: FSR) shares rose 31.3% to $0.2034 in pre-market trading. Fisker shares dipped around 52% on Thursday following a Wall Street Journal report suggesting the company is preparing for a possible bankruptcy filing. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 26.9% to $309.13 in pre-market trading after the company announced FDA approval of Rezdiffra for the treatment of patients with noncirrhotic NASH with moderate to advanced liver fibrosis. 2seventy bio, Inc. (NASDAQ: TSVT) shares gained 18.7% to $4.70 in pre-market trading. On March 5, 2seventy bio posted downbeat quarterly results. American Vanguard Corporation (NYSE: AVD) climbed 16% to $12.28 ...

Related tickers: AQST, KUKE, PBM, BTTX, ADBE, TSVT, KOPN, BREA, PRST, ALCE, ULTA, AVD, FSR, TBIO, PD, MDGL, ADIL, CDLX, BLNK, SMAR.